date,title,source
Oct-24-18,Neurotrope Presents Updated Phase 2 Data of Bryostatin-1 in Moderate to Severe Alzheimer's Disease at the 11th Edition of CTAD,PR Newswire
Nov-19-18,"Report: Developing Opportunities within Command Center, Neurotrope, Selecta Biosciences, InVivo Therapeutics, SeaSpine, and Senestech  Future Expectations, Projections Moving into 2018",GlobeNewswire
